Sawada Y, Rasková J, Fujinaga K, Raska K
Department of Pathology, University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School, Piscataway 08854.
Int J Cancer. 1994 May 15;57(4):598-603. doi: 10.1002/ijc.2910570426.
The adenovirus (Ad) E1A gene induces in immunized animals a strong tumor transplantation (TSTA) immunity against Ad tumors. Such immunity with group-A and group-C viruses is highly group-specific and no cross-protection is detected between serotypes 5 and 12. This fact was used to map the domains of the Ad5 and Ad12 E1A gene products, respectively, which control the TSTA. We constructed a library of 8 recombinant viruses (H5sub1101 through H5sub1108) which carry chimeric Ad5/Ad12 E1A genes in the background of Ad5. The chimeric genes are functional and these viruses are viable. Some of these constructs induce strong and highly specific tumor syngraft immunity in immunized rats. The viruses carrying the 5' terminus of the first E1A exon derived from Ad12 (viruses H5sub1101, H5sub1102 and H5sub1103) induce strong protection against Ad12 tumors irrespective of the rest of their E1A sequence. The viruses which carry the second exon of the Ad5 E1A gene (viruses H5sub1101, H5sub1102 and H5sub1106) protect against group-C tumors, regardless of the origin of the rest of their E1A gene. The 2 viruses that carry the 5' E1A terminus of the first exon of Ad12 and the second exon of Ad5 (H5sub1101 and H5sub1102) are thus effective in inducing immunity against Ad12 tumors as well as against Ad2 tumors. The viruses which carry the 5' terminus of the first exon derived from Ad5 and the second exon of Ad12 (H5sub1107 and H5sub 1108) fail to induce immunity against either tumor. Expression of only the truncated 5' terminus of the Ad12 E1A gene (viruses H5sub1104 and H5sub1105) is sufficient for induction of Ad12 TSTA. Our results provide direct and unequivocal in vivo evidence that TSTA activities of adenovirus groups A and C are controlled by different domains of their respective E1A genes. The Ad12 TSTA is a function of the 5' terminus of the first E1A exon, while the Ad5 TSTA is coded for by the 3' exon of its E1A gene.
腺病毒(Ad)E1A基因在免疫动物中可诱导产生针对Ad肿瘤的强大肿瘤移植(TSTA)免疫力。A组和C组病毒产生的这种免疫力具有高度的组特异性,在血清型5和12之间未检测到交叉保护作用。这一事实被用于分别定位Ad5和Ad12 E1A基因产物中控制TSTA的结构域。我们构建了一个包含8种重组病毒(H5sub1101至H5sub1108)的文库,这些病毒在Ad5的背景下携带嵌合的Ad5/Ad12 E1A基因。嵌合基因具有功能,这些病毒可以存活。其中一些构建体在免疫大鼠中可诱导强烈且高度特异性的肿瘤同基因移植免疫力。携带源自Ad12的第一个E1A外显子5'末端的病毒(病毒H5sub1101、H5sub1102和H5sub1103),无论其E1A序列的其余部分如何,均可诱导对Ad12肿瘤的强大保护作用。携带Ad5 E1A基因第二个外显子的病毒(病毒H5sub1101、H5sub1102和H5sub1106)可预防C组肿瘤,而不考虑其E1A基因其余部分的来源。因此,携带Ad12第一个外显子的5' E1A末端和Ad5第二个外显子的2种病毒(H5sub1101和H5sub1102)在诱导针对Ad12肿瘤以及Ad2肿瘤的免疫力方面是有效的。携带源自Ad5的第一个外显子5'末端和Ad12第二个外显子的病毒(H5sub1107和H5sub 1108)无法诱导针对任何一种肿瘤的免疫力。仅Ad12 E1A基因截短的5'末端的表达(病毒H5sub1104和H5sub1105)就足以诱导Ad12 TSTA。我们的结果提供了直接且明确的体内证据,表明腺病毒A组和C组的TSTA活性由其各自E1A基因的不同结构域控制。Ad12 TSTA是第一个E1A外显子5'末端的功能,而Ad5 TSTA由其E1A基因的3'外显子编码。